0.16
-0.0311(-16.70%)
Currency In USD
| Previous Close | 0.19 |
| Open | 0.18 |
| Day High | 0.19 |
| Day Low | 0.14 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.14 |
| Volume | 2.18M |
| Average Volume | 942,455 |
| Market Cap | 31.26M |
| PE | -0.86 |
| EPS | -0.18 |
| Moving Average 50 Days | 0.31 |
| Moving Average 200 Days | 0.71 |
| Change | -0.03 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $15.6 as of March 05, 2026 at a share price of $0.155. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 3 years ago, it would be worth $13.64 as of March 05, 2026 at a share price of $0.155.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
GlobeNewswire Inc.
4 hours ago
WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transa
Tevogen Announces Reverse Stock Split
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 50 for
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
GlobeNewswire Inc.
Feb 27, 2026 7:20 PM GMT
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSW